Search - tctmd.com

Displaying 1 - 20 of 281

Sort: Relevancy | Date

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

FDA Approves Aficamten for Obstructive HCM

News Daily News

FDA Approves Aficamten for Obstructive HCM

December 29, 2025

TCTMD’s Top 10 Most Popular Stories for December 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2025

Michael O'Riordan

December 29, 2025

Year in Review: Evidence Around AI in Cardiology Grows

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

December 23, 2025

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

News Daily News

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

December 05, 2025

October 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

October 25, 2025

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

October 02, 2025

Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CM

News Conference News HFSA 2025

Acoramidis Halves Cumulative CV Events Within 6 Months: ATTRibute-CM

Yael L. Maxwell

October 01, 2025

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

News Conference News HFSA 2025

CCM-D Delivers Safe, Effective Integrated Therapy in HFrEF

Yael L. Maxwell

September 29, 2025

Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF

News Conference News HFSA 2025

Voice Analysis Picks Up Patients at Risk for HF Hospitalization: COMMUNITY-HF

Yael L. Maxwell

September 29, 2025

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

September 26, 2025

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

News Daily News

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

September 12, 2025

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

News Conference News ESC 2025

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide

August 30, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

July 24, 2025

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

July 14, 2025

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

News Conference News ESC Heart Failure 2025

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

May 19, 2025

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

April 15, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.